125 related articles for article (PubMed ID: 37697173)
1. Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-1: the Effects of Metal Ions and Buffers.
Jakaria SM; Budil DE; Murtagh J
Pharm Res; 2023 Oct; 40(10):2469-2478. PubMed ID: 37697173
[TBL] [Abstract][Full Text] [Related]
2. A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer.
Avanti C; Amorij JP; Setyaningsih D; Hawe A; Jiskoot W; Visser J; Kedrov A; Driessen AJ; Hinrichs WL; Frijlink HW
AAPS J; 2011 Jun; 13(2):284-90. PubMed ID: 21448747
[TBL] [Abstract][Full Text] [Related]
3. Strategies To Stabilize Dalbavancin in Aqueous Solutions; Section 3: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Phosphate Buffer with and without Divalent Metal Ions.
Jakaria SM; Budil DE; Murtagh J
Pharm Res; 2023 Aug; 40(8):2027-2037. PubMed ID: 37118348
[TBL] [Abstract][Full Text] [Related]
4. A new strategy to stabilize oxytocin in aqueous solutions: II. Suppression of cysteine-mediated intermolecular reactions by a combination of divalent metal ions and citrate.
Avanti C; Permentier HP; Dam Av; Poole R; Jiskoot W; Frijlink HW; Hinrichs WL
Mol Pharm; 2012 Mar; 9(3):554-62. PubMed ID: 22257021
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Degradation Kinetics Study of Dalbavancin Hydrochloride Injection Solutions.
Jakaria SM; Budil DE; Murtagh J
J Pharm Sci; 2023 Jul; 112(7):1872-1887. PubMed ID: 36780988
[TBL] [Abstract][Full Text] [Related]
6. The formation of oxytocin dimers is suppressed by the zinc-aspartate-oxytocin complex.
Avanti C; Hinrichs WLJ; Casini A; Eissens AC; Van Dam A; Kedrov A; Driessen AJM; Frijlink HW; Permentier HP
J Pharm Sci; 2013 Jun; 102(6):1734-1741. PubMed ID: 23589380
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer type.
Napaporn J; Thomas M; Svetic KA; Shahrokh Z; Brazeau GA
Pharm Dev Technol; 2000; 5(1):123-30. PubMed ID: 10669926
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of minodronic acid in aqueous solution for parenteral formulation.
Nakamura K; Tanaka T; Saito K; Yokohama S; Sonobe T
Int J Pharm; 2001 Jul; 222(1):91-9. PubMed ID: 11404035
[TBL] [Abstract][Full Text] [Related]
9. Self-buffering antibody formulations.
Gokarn YR; Kras E; Nodgaard C; Dharmavaram V; Fesinmeyer RM; Hultgen H; Brych S; Remmele RL; Brems DN; Hershenson S
J Pharm Sci; 2008 Aug; 97(8):3051-66. PubMed ID: 18023013
[TBL] [Abstract][Full Text] [Related]
10. Stability of gonadorelin and triptorelin in aqueous solution.
Helm VJ; Müller BW
Pharm Res; 1990 Dec; 7(12):1253-6. PubMed ID: 2151342
[TBL] [Abstract][Full Text] [Related]
11. The modifications of the final stages of the complement reaction by alkali metal cations.
Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
[TBL] [Abstract][Full Text] [Related]
12. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.
Barnett GV; Razinkov VI; Kerwin BA; Hillsley A; Roberts CJ
J Pharm Sci; 2016 Mar; 105(3):1066-73. PubMed ID: 26886346
[TBL] [Abstract][Full Text] [Related]
13. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
[TBL] [Abstract][Full Text] [Related]
14. Aspartate buffer and divalent metal ions affect oxytocin in aqueous solution and protect it from degradation.
Avanti C; Oktaviani NA; Hinrichs WL; Frijlink HW; Mulder FA
Int J Pharm; 2013 Feb; 444(1-2):139-45. PubMed ID: 23376504
[TBL] [Abstract][Full Text] [Related]
15. Retention of ionisable compounds on high-performance liquid chromatography. XV. Estimation of the pH variation of aqueous buffers with the change of the acetonitrile fraction of the mobile phase.
Subirats X; Bosch E; Rosés M
J Chromatogr A; 2004 Dec; 1059(1-2):33-42. PubMed ID: 15628122
[TBL] [Abstract][Full Text] [Related]
16. Stability of ertapenem in aqueous solutions.
Zajac M; Cielecka-Piontek J; Jelińska A
J Pharm Biomed Anal; 2007 Jan; 43(2):445-9. PubMed ID: 16914282
[TBL] [Abstract][Full Text] [Related]
17. Stability of lidocaine in aqueous solution: effect of temperature, pH, buffer, and metal ions on amide hydrolysis.
Powell MF
Pharm Res; 1987 Feb; 4(1):42-5. PubMed ID: 3508528
[TBL] [Abstract][Full Text] [Related]
18. Pre-formulation and chemical stability studies of penethamate, a benzylpenicillin ester prodrug, in aqueous vehicles.
Jain R; Wu Z; Bork O; Tucker IG
Drug Dev Ind Pharm; 2012 Jan; 38(1):55-63. PubMed ID: 21696334
[TBL] [Abstract][Full Text] [Related]
19. Ion-exchange of Pb2+, Cu2+, Zn2+, Cd2+, and Ni2+ ions from aqueous solution by Lewatit CNP 80.
Pehlivan E; Altun T
J Hazard Mater; 2007 Feb; 140(1-2):299-307. PubMed ID: 17045738
[TBL] [Abstract][Full Text] [Related]
20. Effect of acetate, citrate, and divalent metal ions on utilization of sodium caseinate by lactic streptococci.
MCDONALD IJ
Can J Microbiol; 1957 Apr; 3(3):411-7. PubMed ID: 13437200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
